5,880 research outputs found
A study of two-phase flow in a reduced gravity environment
A test loop was designed and fabricated for observing and measuring pressure drops of two-phase flow in reduced gravity. The portable flow test loop was then tested aboard the NASA-JSC KC135 reduced gravity aircraft. The test loop employed the Sundstrand Two-Phase Thermal Management System (TPTMS) concept which was specially fitted with a clear two-phase return line and condenser cover for flow observation. A two-phase (liquid/vapor) mixture was produced by pumping nearly saturated liquid through an evaporator and adding heat via electric heaters. The quality of the two-phase flow was varied by changing the evaporator heat load. The test loop was operated on the ground before and after the KC135 flight tests to create a one-gravity data base. The ground testing included all the test points run during the reduced gravity testing. Two days of reduced gravity tests aboard the KC135 were performed. During the flight tests, reduced-gravity, one-gravity, and nearly two-gravity accelerations were experienced. Data was taken during the entire flight which provided flow regime and pressure drop data for the three operating conditions. The test results show that two-phase pressure drops and flow regimes can be accurately predicted in zero-gravity
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Massive research efforts are now underway to develop a cure for HIV
infection, allowing patients to discontinue lifelong combination antiretroviral
therapy (ART). New latency-reversing agents (LRAs) may be able to purge the
persistent reservoir of latent virus in resting memory CD4+ T cells, but the
degree of reservoir reduction needed for cure remains unknown. Here we use a
stochastic model of infection dynamics to estimate the efficacy of LRA needed
to prevent viral rebound after ART interruption. We incorporate clinical data
to estimate population-level parameter distributions and outcomes. Our findings
suggest that approximately 2,000-fold reductions are required to permit a
majority of patients to interrupt ART for one year without rebound and that
rebound may occur suddenly after multiple years. Greater than 10,000-fold
reductions may be required to prevent rebound altogether. Our results predict
large variation in rebound times following LRA therapy, which will complicate
clinical management. This model provides benchmarks for moving LRAs from the
lab to the clinic and can aid in the design and interpretation of clinical
trials. These results also apply to other interventions to reduce the latent
reservoir and can explain the observed return of viremia after months of
apparent cure in recent bone marrow transplant recipients and an
immediately-treated neonate.Comment: 8 pages main text (4 figures). In PNAS Early Edition
http://www.pnas.org/content/early/2014/08/05/1406663111. Ancillary files: SI,
24 pages SI (7 figures). File .htm opens a browser-based application to
calculate rebound times (see SI). Or, the .cdf file can be run with
Mathematica. The most up-to-date version of the code is available at
http://www.danielrosenbloom.com/reboundtimes
Emission Line Galaxies in the STIS Parallel Survey II: Star Formation Density
We present the luminosity function of [OII]-emitting galaxies at a median
redshift of z=0.9, as measured in the deep spectroscopic data in the STIS
Parallel Survey (SPS). The luminosity function shows strong evolution from the
local value, as expected. By using random lines of sight, the SPS measurement
complements previous deep single field studies. We calculate the density of
inferred star formation at this redshift by converting from [OII] to H-alpha
line flux as a function of absolute magnitude and find rho_dot=0.043 +/- 0.014
Msun/yr/Mpc^3 at a median redshift z~0.9 within the range 0.46<z<1.415 (H_0 =
70 km/s/Mpc, Omega_M=0.3, Omega_Lambda=0.7. This density is consistent with a
(1+z)^4 evolution in global star formation since z~1. To reconcile the density
with similar measurements made by surveys targeting H-alpha may require
substantial extinction correction.Comment: 16 preprint pages including 5 figures; accepted for publication in
Ap
Referencing Sources of Molecular Spectroscopic Data in the Era of Data Science: Application to the HITRAN and AMBDAS Databases
The application described has been designed to create bibliographic entries
in large databases with diverse sources automatically, which reduces both the
frequency of mistakes and the workload for the administrators. This new system
uniquely identifies each reference from its digital object identifier (DOI) and
retrieves the corresponding bibliographic information from any of several
online services, including the SAO/NASA Astrophysics Data Systems (ADS) and
CrossRef APIs. Once parsed into a relational database, the software is able to
produce bibliographies in any of several formats, including HTML and BibTeX,
for use on websites or printed articles. The application is provided
free-of-charge for general use by any scientific database. The power of this
application is demonstrated when used to populate reference data for the HITRAN
and AMBDAS databases as test cases. HITRAN contains data that is provided by
researchers and collaborators throughout the spectroscopic community. These
contributors are accredited for their contributions through the bibliography
produced alongside the data returned by an online search in HITRAN. Prior to
the work presented here, HITRAN and AMBDAS created these bibliographies
manually, which is a tedious, time-consuming and error-prone process. The
complete code for the new referencing system can be found at
\url{https://github.com/hitranonline/refs}.Comment: 11 pages, 5 figures, already published online at
https://doi.org/10.3390/atoms802001
- …